-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Atherosclerosis is an important cause of abdominal aortic aneurysm and coronary artery stenosis.
, patients with abdominal aortic aneurysms often combine cardiovascular-related diseases such as coronary heart disease.
During the 8th Northwest Aortic Disease Summit Forum, "Outpatient" magazine invited Dr. Bai Peace, Deputy Director of Thoracic Cardiovascular Surgery at the Second Hospital of Yulin City, to be interviewed and shared his experience in the treatment of patients with abdominal aortic aneurysm cogeneration.
atherosclerosis is an important cause of abdominal aortic aneurysms, but also an important cause of coronary artery stenosis, so abdominal aortic aneurysm patients often combine coronary heart disease.
is it common for patients you come into contact with in your daily work to have coronary heart disease in patients with abdominal aortic aneurysms? In patients with abdominal aortic aneurysms with combined coronary disease, which lesions are generally treated first? Deputy Director of White Peace Physician: In recent years, with the improvement of diagnosis level, the detection rate of abdominal aortic aneurysm gradually increased, and most of the elderly patients over 60 years of age.
Foreign data, about 90% of patients with abdominal aortic aneurysms combined coronary heart disease, the main reason is that abdominal aortic aneurysm patients have a poor systemic vascular base, which increases the probability of combined coronary heart disease, while the risk of internal arteries, brain arteries and other lesions will increase.
in clinical settings, clinicians routinely recommend coronary CTA or DSA testing in patients with abdominal aortic aneurysms;
treatment of abdominal aortic aneurysms with combined coronary disease is generally an individualized selection strategy based on the patient's condition.
If the patient's coronary disease is relatively more critical and urgent, it is recommended to deal with coronary lesions first;
, if the patient's abdominal aortic aneurysm ruptures or is about to rupture, the abdominal aortic aneurysm should be treated before coronary surgery.
Combined with your presentation at this meeting, "One-stop solution to abdominal aortic aneurysm combined coronary heart disease patients 1 case", what factors do you think affect the prognosis of abdominal aortic aneurysm combined coronary heart disease patients, how to improve prognosis? Deputy Director of White Peace Physician: At this meeting, I shared a case of abdominal aortic aneurysm combined with coronary heart failure, a 77-year-old male who was admitted to hospital with chest, back and abdominal pain for 9 hours, with a history of high blood pressure and diabetes, and CTA showing abdominal aortic aneurysms, wall thrombosis, and coronary stenosis.
preoperative evaluation found that the patient's blood test score was only 34%, after consultation with the relevant department decided to deal with coronary disease first.
, the two lesions of the coronary veins were first stent implanted and drug-coated balloon dilation, respectively, by a physician in the department of internal medicine.
symptoms such as chest tightness and shortness of breath improved significantly after surgery, and their blood test scores increased to 52% after 1 week.
subsequently treated abdominal aortic aneurysm with clad stent implantation, and postoperative oculation showed that the stent was in good shape and had no leakage.
discharge, the patient's symptoms disappear and he is in good health.
factors such as the prognosis of the abdominal aortic aneurysm include the size of the tumor, whether it ruptured, the distance from the visceral blood vessels, the length of the tumor neck, the degree of distortion, and the diameter, the condition of the entering blood vessels, etc.
assessment and measurement before surgery, selecting the right stent, precise operation during surgery, and close follow-up management after surgery can all help improve patient prognostication.
For older patients with abdominal aortic aneurysms, there are often multiple cases of comorgoma throughout the body, and the first diagnosis of co-merger, targeted treatment strategies are very important to improve prognosis.
study found that the long-term survival rate of abdominal aortic aneurysm combined coronary heart disease was significantly lower than that of patients with non-combined coronary heart disease, whether coronary heart disease may cause poor prognosis after treatment in patients with abdominal aortic aneurysm? What do you think is the cause of this phenomenon? Deputy Director of White Peace Physician: For the diagnosis and treatment of coronary heart disease abdominal aortic aneurysm, some patients may die due to coronary heart attack, severe arrhyth arrhythmic, or heart failure before surgery.
also some patients, in the treatment of abdominal aortic disease, sudden arrhyth arrhythmic, or heart failure aggravation led to death.
addition, for the combination of coronary heart disease abdominal aortic aneurysm patients postoperative management, including diet, medication and other aspects should also be very careful to avoid the outbreak of coronary heart disease.
note that in-cavity surgery is generally not recommended for young patients with strong tolerance.
most patients with abdominal aortic aneurysms with combined coronary heart disease are older and less to bearable, so in-cavity surgery is generally recommended.
Outpatient Magazine Source: Outpatient New Horizons Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Originals" are owned by Mets Medicine and are not authorized to be reproduced by any media, website or individual, and are authorized to be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here